Kirsten Gillibrand Asks Advocate: How Should Congress Increase Oversight, Transparency Of Rx Drugs?

During a Senate Aging Committee hearing earlier this month, Sen. Kirsten Gillibrand (D-NY) asked Founder & CEO of the Hypertrophic Cardiomyopathy Association Lisa Salberg about transparency for prescription drugs.

Stay Connected
Forbes Breaking News on X: https://x.com/ForbesTVNews
Forbes Breaking News on TikTok: https://www.tiktok.com/@forbestvnews
More From Forbes: http://forbes.com